Hans-Peter Brunner-La Rocca

Professor

Prof. Hans-Peter Brunner-La Rocca has graduated in medicine at the University of Zurich, Switzerland. He was trained in Internal Medicine and Cardiology in Switzerland. After doing a post-doc in Melbourne, Australia, for two years, he had been working as cardiologist and heart failure specialist in Zurich. In 2002, he moved to Basel, where he was responsible for the heart failure and heart transplant services. He has obtained his lecture qualification both in Zurich and in Basel and was announced as Professor in Basel Switzerland in 2008. Since 2009, he has been working at Maastricht UMC+ as Professor of Clinical Heart Failure. He is head of the heart failure clinic and head of the division of structural heart diseases.

He has been involved in numerous research projects since many years. In particular, he has a special interest in personalised medicine in heart failure using biomarkers and has successfully led international studies related to this topic. In addition, eHealth is an important focus of research. He has published >250 research articles.

He has been working as member of different working groups of the Heart Failure Association of the European Society of Cardiology and is board member of working group on heart failure in the Netherlands.

On the one hand, he is continuing his research on biomarker in heart failure for therapy guidance. He is collaborating internationally on this topic and is participating in several large international projects in this regard. On the other hand, he is leading an international consortium, aiming to develop a personalized eHealth application to enable patients with heart failure to perform self-care, i.e. including self-prescription of medication. Recently, the consortium received 4.4 M€ to support this project from INTERREG-NWE (budget Maastricht UMC+ > 2.0 M€).

He is additionally involved in national research projects (e.g. heart-brain connection, supported by CVON) and is the local PI of several large industry sponsored RCTs. In one of them, he is the national coordinator for the Netherlands.

Department of Cardiology
P. Debyelaan 25, 6229 HX Maastricht 
PO Box 5800, 6202 AZ Maastricht
Room number: 3.B2.031
T: +31(0)43 387 70 97

  • 2022
    • Gingele, A. J., Brandts, L., Brunner-La Rocca, H. P., Cleuren, G., Knackstedt, C., & Boyne, J. J. J. (2022). Introduction of a new scoring tool to identify clinically stable heart failure patients. Netherlands Heart Journal, 30(9), 402-410. https://doi.org/10.1007/s12471-021-01654-8
    • van Stipdonk, A. M. W., Schretlen, S., Dohmen, W., Knackstedt, C., Beckers-Wesche, F., Debie, L., Brunner-La Rocca, H-P., & Vernooy, K. (2022). Better outcome at lower costs after implementing a CRT-care pathway: comprehensive evaluation of real-world data. Esc heart failure, 9(4), 2518-2527. https://doi.org/10.1002/ehf2.13958
    • Vergaro, G., Gentile, F., Aimo, A., Januzzi, J. L., Richards, A. M., Lam, C. S. P., de Boer, R. A., Meems, L. M. G., Latini, R., Staszewsky, L., Anand, I. S., Cohn, J. N., Ueland, T., Gullestad, L., Aukrust, P., Brunner-La Rocca, H-P., Bayes-Genis, A., Lupón, J., Yoshihisa, A., ... Emdin, M. (2022). Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure. Esc heart failure, 9(4), 2084-2095. https://doi.org/10.1002/ehf2.13883
    • Henkens, M. T. H. M., Martinez, H. L., Weerts, J., Sammani, A., Raafs, A. G., Verdonschot, J. A. J., van de Leur, R. R., Sikking, M. A., Stroeks, S., van Empel, V. P. M., Brunner-La Rocca, H. P., van Stipdonk, A. M. W., Farmakis, D., Hazebroek, M. R., Vernooy, K., Bayes-de-Luna, A., Asselbergs, F. W., Bayes-Genis, A., & Heymans, S. R. B. (2022). Interatrial Block Predicts Life-Threatening Arrhythmias in Dilated Cardiomyopathy. Journal of the American Heart Association, 11(14), [e025473]. https://doi.org/10.1161/JAHA.121.025473
    • Veugen, M. G. J., Onete, V. G., Henry, R. M. A., Brunner-La Rocca, H-P., Koster, A., Dagnelie, P. C., Schaper, N. C., Sep, S. J. S., van der Kallen, C. J. H., van Boxtel, M. P. J., Reesink, K. D., Schouten, J. S., Savelberg, H. H. C. M., Köhler, S., Verhey, F. R., van den Bergh, J. P. W., Schram, M. T., & Stehouwer, C. D. A. (2022). Health burden in type 2 diabetes and prediabetes in The Maastricht Study. Scientific Reports, 12(1), 1-11. [7337]. https://doi.org/10.1038/s41598-022-11136-5
    • Verdonschot, J. A. J., Ferreira, J. P., Pizard, A., Pellicori, P., Brunner La Rocca, H-P., Clark, A. L., Cosmi, F., Cuthbert, J., Girerd, N., Waring, O. J., Henkens, M. H. T. M., Mariottoni, B., Petutschnigg, J., Rossignol, P., Hazebroek, M. R., Cleland, J. G. F., Zannad, F., Heymans, S. R. B., & HOMAGE “Heart Omics in AGEing” consortium (2022). The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE Trial. Journal of Cardiac Failure, 28(5), 778-786. https://doi.org/10.1016/j.cardfail.2021.12.005
    • Ferreira, J. P., Collier, T., Clark, A. L., Mamas, M. A., Rocca, H-P. B-L., Heymans, S., González, A., Ahmed, F. Z., Petutschnigg, J., Mujaj, B., Cuthbert, J., Rouet, P., Pellicori, P., Mariottoni, B., Cosmi, F., Edelmann, F., Thijs, L., Staessen, J. A., Hazebroek, M., ... Zannad, F. (2022). Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial. European Heart Journal-Cardiovascular Pharmacotherapy, 8(2), 149-156. https://doi.org/10.1093/ehjcvp/pvab031
    • van Dalen, D. H., Kragten, J. A., Emans, M. E., Van Ofwegen-Hanekamp, C. E. E., Klaarwater, C. C. R., Spanjers, M. H. A., Hendrick, R., van Deursen, C. T. B. M., & Brunner-La Rocca, H. P. (2022). Acute heart failure and iron deficiency: a prospective, multicentre, observational study. Esc heart failure, 9(1), 398-407. https://doi.org/10.1002/ehf2.13737
    • Uszko-Lencer, N. H. M. K., Janssen, D. J. A., Gaffron, S., Vanfleteren, L. E. G. W., Janssen, E., Werter, C., Franssen, F. M. E., Wouters, E. F. M., Rechberger, S., Brunner La Rocca, H-P., & Spruit, M. A. (2022). Clustering based on comorbidities in patients with chronic heart failure: an illustration of clinical diversity. Esc heart failure, 9(1), 614-626. https://doi.org/10.1002/ehf2.13704
    • Radhoe, S. P., Veenis, J. F., Linssen, G. C. M., van der Lee, C., Eurlings, L. W. M., Kragten, H., Al-Windy, N. Y. Y., van der Spank, A., Koudstaal, S., Brunner-La Rocca, H. P., & Brugts, J. J. (2022). Diabetes and treatment of chronic heart failure in a large real-world heart failure population. Esc heart failure, 9(1), 353-362. https://doi.org/10.1002/ehf2.13743